Pfizer
Pfizer explores sale of some treatment drugs worth over $2 bn
03 Feb 2017
As a part of its plan to raise cash and streamline its portfolio, Pfizer will sell its cardiology, urology and primary care treatment drugs
After Pfizer, Actavis accused of hiking drug price by 12,000%
17 Dec 2016
A week after Pfizer was slapped with a record fine of £84.2 million for unfair price hikes, the UK’s Competition and Markets Authority has accused Actavis of hiking the price of a drug from 70p to £88 a pack
Pfizer fined for 2,600% price hike
08 Dec 2016
Pfizer in advanced talks to buy cancer drug specialist Medivation for nearly $14 bn
22 Aug 2016
A successful deal would be Pfizer’s biggest acquisition since it purchased biologic drug specialist Hospira Inc last year for about $17 billion
